Consolidated Balance Sheet (Unaudited) (USD $) In Millions	Jun. 30, 2011	Dec. 31, 2010
Current Assets
Cash and cash equivalents	$ 12,342	$ 10,900
Short-term investments	1,639	1,301
Accounts receivable (net of allowance for doubtful accounts of $128 in 2011 and $104 in 2010)	8,475	7,344
Inventories (excludes inventories of $1,408 in 2011 and $1,194 in 2010 classified in Other assets - see Note 6)	6,225	5,868
Deferred income taxes and other current assets	3,687	3,651
Total current assets	32,368	29,064
Investments	2,175	2,175
Property, Plant and Equipment, at cost, net of accumulated depreciation of $15,195 in 2011 and $13,481 in 2010	16,671	17,082
Goodwill	12,382	12,378
Other Intangibles, Net	37,065	39,456
Other Assets	5,534	5,626
Total Assets	106,195	105,781
Current Liabilities
Loans payable and current portion of long-term debt	2,523	2,400
Trade accounts payable	2,143	2,308
Accrued and other current liabilities	8,747	8,514
Income taxes payable	1,174	1,243
Dividends payable	1,176	1,176
Total current liabilities	15,763	15,641
Long-Term Debt	15,783	15,482
Deferred Income Taxes and Noncurrent Liabilities	16,727	17,853
Merck & Co., Inc. Stockholders' Equity
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,576,948,356 shares in 2011 and 2010	1,788	1,788
Other paid-in capital	40,657	40,701
Retained earnings	38,243	37,536
Accumulated other comprehensive loss	(2,776)	(3,216)
Stockholders' equity before deduction for treasury stock	77,912	76,809
Less treasury stock, at cost 493,935,906 shares in 2011 and 494,841,533 shares in 2010	22,416	22,433
Total Merck & Co., Inc. stockholders' equity	55,496	54,376
Noncontrolling Interests	2,426	2,429
Total equity	57,922	56,805
Liabilities and Equity	$ 106,195	$ 105,781